NCT04504942 2026-01-23
Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors
CytoDyn, Inc.
Phase 2 Completed
CytoDyn, Inc.
Memorial Sloan Kettering Cancer Center
Swiss Cancer Institute
National Cancer Institute (NCI)
Fox Chase Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
St. Jude Children's Research Hospital
Fox Chase Cancer Center